Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
COO Stock Forecast 2026-2027
$67.88
Current Price
$13.24B
Market Cap
Buy 10
Hold 5
Sell 1
Wall St Analyst Ratings
Distance to COO Price Targets
+35.5%
To High Target of $92.00
+25.2%
To Median Target of $85.00
-2.8%
To Low Target of $66.00
COO Price Momentum
+1.6%
1 Week Change
+13.9%
1 Month Change
-2.6%
1 Year Change
-17.2%
Year-to-Date Change
-24.4%
From 52W High of $89.83
+15.3%
From 52W Low of $58.89
📊 TOP ANALYST CALLS
Did COO Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if CooperCompanies is one of their latest high-conviction picks.
Latest COO Stock Price Targets & Analyst Predictions
Based on our analysis of 23 Wall Street analysts, COO has a bullish consensus with a median price target of $85.00 (ranging from $66.00 to $92.00). The overall analyst rating is Buy (7.8/10). Currently trading at $67.88, the median forecast implies a 25.2% upside. This outlook is supported by 10 Buy, 5 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Navann Ty at BNP Paribas, projecting a 35.5% upside. Conversely, the most conservative target is provided by Larry Biegelsen at Wells Fargo, suggesting a 2.8% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
COO Analyst Ratings
10
Buy
5
Hold
1
Sell
COO Price Target Range
Low
$66.00
Average
$85.00
High
$92.00
Current: $67.88
Latest COO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for COO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 8, 2026 | BNP Paribas | Navann Ty | Outperform | Maintains | $92.00 |
| Jun 5, 2026 | JP Morgan | Robbie Marcus | Neutral | Maintains | $71.00 |
| Jun 5, 2026 | Stifel | Jonathan Block | Buy | Maintains | $85.00 |
| Jun 5, 2026 | Wells Fargo | Larry Biegelsen | Equal-Weight | Maintains | $66.00 |
| Jun 5, 2026 | Needham | David Saxon | Buy | Maintains | $86.00 |
| Jun 5, 2026 | Baird | Jeff Johnson | Outperform | Maintains | $85.00 |
| Jun 4, 2026 | Mizuho | Anthony Petrone | Outperform | Maintains | $85.00 |
| Jun 1, 2026 | Piper Sandler | Jason Bednar | Overweight | Reiterates | $86.00 |
| May 28, 2026 | Citigroup | Neutral | Maintains | $N/A | |
| Mar 6, 2026 | Citigroup | Neutral | Maintains | $N/A | |
| Mar 6, 2026 | Barclays | Overweight | Maintains | $N/A | |
| Mar 6, 2026 | Needham | Buy | Maintains | $N/A | |
| Feb 3, 2026 | Needham | Buy | Maintains | $N/A | |
| Jan 26, 2026 | Barclays | Overweight | Maintains | $N/A | |
| Dec 8, 2025 | Citigroup | Neutral | Maintains | $N/A | |
| Dec 8, 2025 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| Dec 8, 2025 | Goldman Sachs | Sell | Maintains | $N/A | |
| Dec 5, 2025 | Stifel | Buy | Reiterates | $N/A | |
| Dec 5, 2025 | Piper Sandler | Overweight | Reiterates | $N/A | |
| Dec 5, 2025 | Wells Fargo | Equal-Weight | Maintains | $N/A |
The Cooper Companies, Inc. (COO) Competitors
The following stocks are similar to CooperCompanies based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
COO
Cooper Surgical
mkt cap
13.24B
The Cooper Companies, Inc. (COO) Financial Data
The Cooper Companies, Inc. has a market capitalization of $13.24B with a P/E ratio of 57.5x. The company generates $4.23B in trailing twelve-month revenue with a 5.6% profit margin.
Revenue growth is +7.9% quarter-over-quarter, while maintaining an operating margin of -2.9% and return on equity of +2.9%.
Valuation Metrics
Market Cap
$13.24B
Enterprise Value
$15.83B
P/E Ratio
57.5x
PEG Ratio
-0.3x
Price/Sales
3.1x
Growth & Margins
Revenue Growth (YoY)
+7.9%
Gross Margin
+68.0%
Operating Margin
-2.9%
Net Margin
+5.6%
EPS Growth
+7.9%
Financial Health
Cash/Price Ratio
+1.0%
Current Ratio
1.3x
Debt/Equity
33.1x
ROE
+2.9%
ROA
+2.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
The Cooper Companies, Inc. (COO) Business Model
About The Cooper Companies, Inc.
What They Do
Global company specializing in eyecare and women's health.
Business Model
The Cooper Companies operates through two primary segments: CooperVision and CooperSurgical. CooperVision generates revenue by developing and marketing a diverse range of contact lenses targeting various vision conditions, while CooperSurgical earns income by providing medical devices and consumables for fertility and women's health, serving hospitals and clinics.
Additional Information
Headquartered in San Ramon, California, The Cooper Companies is a significant player in the soft contact lens market and offers essential products in reproductive care, making it well-positioned in both the eyecare and women's health sectors.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
15,000
CEO
Mr. Albert G. White III
Country
United States
IPO Year
1983
Website
www.coopercos.comThe Cooper Companies, Inc. (COO) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Here's Why The Cooper Companies (COO) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Jun 12, 2026
By Zacks Equity Research
Tale of the Tape
Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Jun 09, 2026
By Zacks Equity Research
Tale of the Tape
The Cooper Companies (COO) Reliance on International Sales: What Investors Need to Know
Evaluate The Cooper Companies' (COO) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Jun 08, 2026
By Zacks Equity Research
Fundamental Analysis
Latest News
Quick Summary
Zacks Style Scores can aid investors in selecting strong stocks that outperform the market for their investment portfolios.
Why It Matters
The Zacks Style Scores can help identify high-potential stocks, aiding investors in selecting stocks likely to outperform the market, enhancing portfolio performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
The Cooper Companies receives a hold rating due to strong demand for contact lenses but faces challenges in margin and ROE improvement compared to peers like Alcon and Johnson & Johnson.
Why It Matters
The hold rating reflects strong demand for contact lenses but highlights challenges in margins and return on equity compared to peers, impacting growth potential and competitive positioning.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
The Cooper Companies' financial stability and growth prospects may be influenced by its reliance on international revenue, which could affect stock price performance.
Why It Matters
The Cooper Companies' international revenue reliance impacts financial stability, growth potential, and stock valuation, influencing investor confidence and market performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Zacks Premium offers a feature called Zacks Style Scores, which aids value, growth, and momentum investors in identifying strong stocks.
Why It Matters
The Zacks Style Scores can enhance stock selection for various investment strategies, potentially leading to better returns and informed decision-making.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
The Cooper Companies, Inc. maintains a Hold rating due to litigation risks and mixed profitability. Revenue growth is strong, especially in CooperVision, despite challenges in Asia Pacific.
Why It Matters
The Cooper Companies' mixed profitability and litigation risks may affect short-term performance, but strong revenue growth, especially in CooperVision, supports a stable long-term outlook.
Source: Seeking Alpha
Market Sentiment:
Positive
Cooper Companies Q2 Earnings Call Highlights
10 days ago
Quick Summary
Cooper Companies (COO) reported record revenue and non-GAAP earnings for Q2 2026 and is in discussions with multiple parties regarding CooperSurgical as part of a strategic review.
Why It Matters
Record revenue and earnings signal strong financial health, while potential divestiture of CooperSurgical may unlock value, impacting shareholder returns and strategic focus.
Source: MarketBeat
Market Sentiment:
Neutral
Frequently Asked Questions About COO Stock
What is The Cooper Companies, Inc.'s (COO) stock forecast for 2026?
Based on our analysis of 23 Wall Street analysts, The Cooper Companies, Inc. (COO) has a median price target of $85.00. The highest price target is $92.00 and the lowest is $66.00.
Is COO stock a good investment in 2026?
According to current analyst ratings, COO has 10 Buy ratings, 5 Hold ratings, and 1 Sell ratings. The stock is currently trading at $67.88. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for COO stock?
Wall Street analysts predict COO stock could reach $85.00 in the next 12 months. This represents a 25.2% increase from the current price of $67.88. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is The Cooper Companies, Inc.'s business model?
The Cooper Companies operates through two primary segments: CooperVision and CooperSurgical. CooperVision generates revenue by developing and marketing a diverse range of contact lenses targeting various vision conditions, while CooperSurgical earns income by providing medical devices and consumables for fertility and women's health, serving hospitals and clinics.
What is the highest forecasted price for COO The Cooper Companies, Inc.?
The highest price target for COO is $92.00 from Navann Ty at BNP Paribas, which represents a 35.5% increase from the current price of $67.88.
What is the lowest forecasted price for COO The Cooper Companies, Inc.?
The lowest price target for COO is $66.00 from Larry Biegelsen at Wells Fargo, which represents a -2.8% decrease from the current price of $67.88.
What is the overall COO consensus from analysts for The Cooper Companies, Inc.?
The overall analyst consensus for COO is bullish. Out of 23 Wall Street analysts, 10 rate it as Buy, 5 as Hold, and 1 as Sell, with a median price target of $85.00.
How accurate are COO stock price projections?
Stock price projections, including those for The Cooper Companies, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 15, 2026 7:45 AM UTC